Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1994-01-25
1995-12-12
Chan, Christina Y.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
53038885, 5303892, C07K 1628
Patent
active
054750911
ABSTRACT:
The present invention relates to intercellular adhesion molecules (ICAM-1) which are involved in the process through which lymphocytes recognize and migrate to sites of inflammation as well as attach to cellular substrates during inflammation. The invention is directed toward such molecules, screening assays for identifying such molecules and antibodies capable of binding such molecules. The invention also includes uses for adhesion molecules and for the antibodies that are capable of binding them.
REFERENCES:
patent: 4748018 (1988-05-01), Stolle et al.
Kavanaugh et al., 56th Annual Scientific Meeting of the American College of Rheumatology, Oct. 11-15, 1992.
Kavanaugh et al., Arthritis & Rheumatism, vol. 37, No. 7, pp. 992-999, 1994.
Hang et al., Transplantation, vol. 55, pp. 766-773, No. 4, (1993).
Borrebaeck, Journal of Immunological Methods, vol. 123, pp. 157-165 (1989).
Osband et al., Immunology Today, vol. 11, No. 6, pp. 193-195 (1990).
Konrad, Biological Barriers to Protein Delivery (Audus et al., eds), Plenum Press, New York, pp. 409-437 (1993).
Dillman, Annals of Internal Medicine, vol. 111, No. 7, pp. 592-602 (1989).
Gaifre, Methods in Enzymology, vol. 73, pp. 3-47 (1981).
Alexander, E. L. et al., Cutaneous Manifestations of Sjorgen's Syndrome, in Jordon, R. E. ed., Immunologic Diseases of the Skin, Appleton & Lange, Norwalk, Conn., San Mateo, Calif., pp. 401-408 (1991).
Anderson, D. C. et al., Leukocyte LFA-1, OKMI, p. 150, 95, deficiency syndrome: functional and biosynthetic studies of three kindreds, Fed. Proceedings 44(10): 2671-2677 (Jul. 1985).
Anderson, D. C. et al., Leukocyte Adhesion Deficiency: An Inherited Defect in the Mac-1, LFA-1, and p150, 95 Glycoproteins, Ann. Rev. Med. 38:175-194 (1987).
Bashir, R. et al., Expression of LFA-ICAM-1 in CNS lymphomas: possible mechanism for lymphoma homing into the brain, J. Neuro-Oncol. 12:103-110 (1992).
Boyd, A. W. et al., Intercellular adhesion molecule 1 (ICAM-1) has a central role in cell-cell contact-mediated immune mechanisms, Proc. Natl. Acad. Sci. USA 85:3095-3099 (May 1988).
Byers, V. S. et al., Use of an Anti-Pan T-Lymphocyte Ricin A Chain Immunotoxin in Steroid-Resistant Acute Graft-Versus-Host Disease, Blood 75 (7): 1426-1432 (Apr. 1, 1990).
Colonno, R. J. et al., Isolation of Monoclonal Antibody That Blocks Attachment of the Major Group of Human Rhinoviruses, J. Virol. 57(1): 7-12 Jan. 1986).
Cooper, K. D. et al., Immunologic Features of Psoriasis, in Jordon, R. E., ed., Immunologic Diseases of the Skin, Appleton & Lange, Norwalk, Conn., San Mateo, Calif. pp. 611-619 (1991).
Cosimi, A. B. et al., In Vivo Effects of Monoclonal Antibody to ICAM-1 (CD54) In Nonhuman Primates With Renal Allografts, J. Immunol. 144(12): 4604-4612 (Jun. 15, 1990).
Cunningham, C. et al., Antibody engineering --how to be human, TIBTECH 10 (Apr. 1992).
Dantal, J. et al., Use of monoclonal antibodies in human transplantation, Curr. Opin, Immunol. 3:740-747 (1991).
Davignon, D. et al., Lymphocyte function-associated antigen 1 (LFA-1): A surface antigen distinct from Lyt-2, 3 that participates in T lymphocyte-mediated killing, Proc. Natl. Acad. Sci. USA 78: 4535-4539 (Jul. 1981).
Dustin , M. L. et al., Adhesion of T Lymphoblasts To Epidermal Keratinocytes Is Regulated By Interferon .lambda. And Is Mediated By Intercellular Adhesion Molecule 1 (ICAM-1), J. Exp. Med. 167: 1323-1340 (Apr. 1988).
Dustin, M. L. et al., Induction by IL 1 and Interferon-.tau.: Tissue Distribution, Biochemistry, And Function Of A Natural Adherence Molecule (ICAM-1), J. Immunol. 137(1):245-254 (Jul. 1, 1986).
Dustin, M. L. et al., Lymphocyte Function-associated Antigen-1 (LFA-1) Interaction with Intercellular Adhesion Molecule-1 (ICAM-1) is One of At Least Three Mechanisms for Lymphocyte Adhesion to Cultured Endothelial Cells, J. Cell Biol. 107: 321-331 (Jul. 1988).
Dustin, M. L. et al., Purified Lymphocyte Function-Associated Antigen 3 Binds To CD2 And Mediates T Lymphocyte Adhesion, J. Exp. Med. 165: 677-692 (Mar. 1987).
Dustin, M. L. et al., Supergene families meet in the immune system, Immunol. Today 9 (7&8): 213-215 (1988).
Dustin, M. L. et al., T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1, Nature 341: 619-624 (Oct. 19, 1989).
Fischer, A. et al., Role of The LFA-1 Molecule In Cellular Interactions Required For Antibody Production In Humans, J. Immunol. 136(9): 3198-3203 (May 1, 1986).
Flavin, T. et al., Monoclonal Antibodies Against Intercellular Adhesion Molecule 1 Prolong Cardiac Allograft Survival in Cynomolgus Monkeys, Transplant. Proc. 23(1): 533-534 (Feb. 1991).
Gibbs, Try, Try Again: Making antibodies more useful by making them more human, Scientific American: 101-103 (Jul. 1993).
Hamann, A. et al., Evidence For An Accessory Role of LFA-1 In Lymphocyte-High Endothelium Interaction During Homing, J. Immunol. 140(3): 693-699 (Feb. 1, 1988).
Harlan, J. M. et al., Leukocyte-Endothelial Interactions, Blood 65(3): 513-525 (Mar. 1985).
Harris, W. J. et al., Therapeutic antibodies-the coming of age, TIBTECH 11: 42-44 (Feb. 1993).
Haskard, D. et al., T Lymphocyte Adhesion To Endothelial Cells: Mechanisms Demonstrated By Anti-LFA-1 Monoclonal Antibodies, J. Immunol. 137: 2901-2906 (Nov. 1986).
Haug, C. E. et al., A Phase I Trial of Immunosuppression With Anti-ICAM-1 (CD54) mAb In Renal Allograft Recipients, Transplantation 55(4): 766-773 (Apr. 1993).
Hildreth, J. E. K. et al., Involvement of a Leukocyte Adhesion Receptor (LFA-1) in HIV-Induced Syncytium Formation, Science 244: 1075-1078 (Jun. 2, 1989).
Hoffman, P. M. et al., Neurologic Diseases, in Stites, D. P. et al., eds., Basic & Clinical Immunology, Sixth Edition, Appleton & Lange, Norwalk, Conn., San Mateo, Calif., pp. 598-602 (1987).
Jonker, M. et al., Successful Treatment of EAE in Rhesus Monkeys with MHC Class II Specific Monoclonal Atibodies, J. Autoimmunity 1: 399-414 (1988).
Kageshita, T. et al., Differential Expression of Melanoma Associated Antigens in Acral Lentiginous Melanoma and in Nodular Melanoma Lesions, Cancer Res. 51: 1726-1732 (Mar. 15, 1991).
Kavanaugh, A. F. et al., Treatment of Refractory Rheumatoid Arthritis With An Anti-CD54 (Intercellular Adhesion Molecule-1, ICAM-1) Monoclonal Antibody, Abstr. Proc. Amer. Coll. Rheumatology (1992).
Keizer, G. D. et al., Biochemical and functional characteristics of the human leukocyte membrane antigen family LFA-1, Mo-1 and p150, 95, Eur. J. Immunol. 15: 1142-1147 (1985).
Kishimoto, T. K. et al., The Leukocyte Integrins, Adv. Immunol. 46: 149-182 (1989).
Kohl, S. et al., Defective Natural Killer Cytotoxicity And Polymorphonuclear Leukocyte Antibody-Dependent Cellular Cytotoxicity in Patients With LFA-1/OKM-1 Deficiency, J. Immunol. 133(6): 2972-2978 (Dec. 1984).
Krensky, A. M. et al., LFA-1, LFA-2 and LFA-3 Antigens Are Involved in CTL-Target Conjugation, J. Immunol. 132(5): 2180-2182 (May 1984).
Makgoba, M. W. et al., Functional evidence that intercellular adhesion molecule-1 (ICAM-1) is a ligand for LFA-1-dependent adhesion in T cell-mediated cytotoxicity, Eur. J. Immunol. 18: 637-640 (1988).
Makgoba, M. W. et al., ICAM-1 a ligand for LFA-1-dependent adhesion of B, T and myeloid cells, Nature 331: 86-88 (Jan. 7, 1988).
Makgoba, M. W. et al., The CD2-LFA-3 and LFA-1 ICAM pathways: relevance to T-cell recognition, Immunol. Today 10: 417-422 (1989).
Marlin, S. D. et al., Purified Intercellular Adhesion Molecule-1 (ICAM-1) Is a Ligand for Lymphocyte Function-Associated Antigen 1 (LFA-1), Cell 51: 813-819 (Dec. 4, 1987).
Mayes, J. T. et al., Reexposure To OKT3 In Renal Allograft Recipients, Transplantation 45(2): 349-353 (Feb. 1988)
Meurer, M. et al., Systemic Scleroderma, Localized Scleroderma, Mixed Connective Tissue Disease, in Jordon, R. E., ed., Immunologic Diseases of the Skin, Aplleton & Lange, Norwalk, Conn., San Mateo, Calif., pp. 389-397 (1991).
Natali, P. et al., Differential Expression of Intercellular Adhesion Molecule 1 in Primary and Metastatic Melanoma Lesions, Cancer Res. 50: 1271-1278 (Feb. 15, 1990).
O'Connell, J. B. et al., Efficacy of OKT3 Retreatment For Refractory Cardiac Allograft Rejec
Dustin Michael L.
Marlin Steven D.
Rothlein Robert
Springer Timothy A.
Chan Christina Y.
The Dana Farber Cancer Institute
LandOfFree
R6-5-D6, an antibody which binds intercellular adhesion molecule does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with R6-5-D6, an antibody which binds intercellular adhesion molecule, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and R6-5-D6, an antibody which binds intercellular adhesion molecule will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1360704